Electrophysiological studies of the cholecystokininA receptor antagonists SR27897B and PD140548 in the rat isolated nodose ganglion

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 6, 1996, Pages 693-697

  Beart, Philip M ^a   Krstew, Elena ^a   Widdop, Robert E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cholecystokinin; Depolarisation; Rat nodose ganglion; Receptor antagonists; Receptor subtypes

Indexed keywords

ALPHA METHYL N [(TRICYCLO[3.3.1.1 3,7]DEC 2 YLOXY)CARBONYL]TRYPTOPHYL DEXTRO 3 BENZYL BETA ALANINE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; LINTITRIPT; RECEPTOR SUBTYPE; SR 278976; UNCLASSIFIED DRUG; CHOLECYSTOKININ RECEPTOR; HORMONE ANTAGONIST; INDOLEACETIC ACID DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG ANTAGONISM; ELECTROPHYSIOLOGY; NODOSE GANGLION; NONHUMAN; RAT; ANIMAL; DOSE RESPONSE; DRUG EFFECT; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HORMONE ANTAGONISTS; INDOLEACETIC ACIDS; NODOSE GANGLION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ; THIAZOLES;

EID: 0029664775     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00167190     Document Type: Article

References (23)

1. Boden PR, Higginbottom M, Hill DR, Horwell DC, Hughes J, Rees DC, Roberts E, Singh L, Suman-Chauhan N, Woodruff GN (1993) Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists. J Med Chem 36:552-565
2. 28, 31)-CCK 25-33S. Eur J Neurosci 4:563-573
3. Crawley JN, Corwin RL (1994) Biological actions of cholecystokinin. Peptides 15:731-755
4. D'Amato M, Rovati LC (1995) CCK-A antagonists: which and how. Eur J Clin Invest 25:213-214
5. Dockray GJ (1988) Regulatory peptides and the neuroendocrinology of gut-brain relations. Q J Exp Physiol 73:703-727
6. Douglas BR, Woutersen RA, Jansen JBMJ, Jong AJL de, Rovati LC, Lamers CBHW (1989a) Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Cancer Res 49:2438-2441
7. Douglas BR, Woutersen RA, Jansen JBMJ, Rovati LC, Lamers CBHW (1989b) Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hamsters. Eur J Pharmacol 161:209-214
8. Furchgott (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blashko H, Muscholl E (eds) Handbook of experimental pharmacology, vol 33 Springer, Berlin Heidelberg New York, pp 283-335
9. Gallego R, Eyzaguirre C (1978) Membrane and action potential characteristics of A and C nodose ganglion cells studied in whole ganglia and in tissue slices. J Neurophysiol 41:1217-1232
10. A receptors. Eur J Pharmacol 232:13-19
11. B/gastrin receptors. Ann NY Acad Sci 713:283-297
12. Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN (1990) Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 87:6728-6732
13. Innis RB, Snyder SH (1980) Cholecystokinin receptor binding in brain and pancreas: regulation of pancreatic binding by cyclic nucleotides. Eur J Pharmacol 65:123-124
14. Lamers CBHW, Jansen JBMJ, Woutersen RA (1990) Cholecystokinin and gastrointestinal cancer. J Steroid Biochem Molec Biol 37:1069-1072
15. Lentner C (1982) Documenta Geigy Scientific Tables. 8th ed, Ciba Geigy, Basel, pp 210-215
16. Mei N (1985) Intestinal chemosensitivity. Physiol Rev 65:211-237
17. Meyer BM, Beglinger C, Jansen JBM, Rovati LC, Werth BA, Hildebrand P, Zach D, Stadler GA (1989) Role of cholecystokinin in regulation of gastrointestinal motor function. Lancet 11:12-15
18. Raybould HE, Tache Y (1988) Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol 255:G242-G246
19. Walsh JH (1987) Gastrointestinal hormones: cholecystokinin. In: Johnson LR, Christensen J, Jackson MJ, Jacobson ED, Walsh JH (eds) Physiology of the gastrointestinal tract, 2 edn. Raven Press, New York, pp 181-253
20. Wank SA, Pisegna JR, De Weerth A (1994) Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human. Ann NY Acad Sci 713:49-66
21. Widdop RE, Krstew E, Jarrott B (1990) Temperature dependence of angiotensin II-mediated depolarisation of the rat isolated nodose ganglion. Eur J Pharmacol 185:107-111
22. Widdop RE, Krstew E, Mercer LD, Carlberg M, Beart PM, Jarrott B (1993) Electrophysiological and autoradiographic evidence for cholecystokinin A receptors on rat isolated nodose ganglia. J Autonom Nerv System 46:65-73
23. Woll PJ, Rozengurt E (1989) Multiple neuropeptides mobilise calcium in small lung cell cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin. Biochem Biophys Res Commun 164:66-73